Purchase Order 36C24420P0596
Award Date 6/12/20
Potential Completion Date 6/12/25
Potential Value $3.4M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sharpsburg, PA 15215, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of HIV reagents to the Department of Veterans Affairs (VA) Veterans Health Administration. The $117,225.68 firm fixed-price contract was awarded to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and related products and services. The contract was issued through the VA's Veterans Integrated Service Network 4 and is not designated as a set-aside. Roche Diagnostics holds multiple General...
- The Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a definitive firm fixed-price contract to Roche Diagnostics Corporation on November 1, 2019, for molecular HIV polymerase chain reaction (PCR) cost-per-test services and equipment lease. The contract, valued at approximately $2.51 million with an ultimate completion date of May 31, 2025, was awarded without a set-aside designation through open competition. The award stems from a pre-solicitation opportunity posted...
- This federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, is a Firm Fixed Price Delivery Order with a ceiling value of $240,369.00. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 9. The contract does not have a set-aside designation. Roche Diagnostics provides a comprehensive range of laboratory equipment, testing systems, reagents, and clinical testing...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Roche Diagnostics Corporation for HCV and HIV viral load testing services. The $104,452.66 contract was awarded on October 5, 2021 through the Critical Analyzers, Laboratory GSA Schedule contract, with a completion date of April 4, 2022. Roche Diagnostics, as a foreign-owned for-profit manufacturer, has provided laboratory instruments, reagents, and testing services to various federal...
- The Department of Veterans Affairs Veterans Health Administration awarded a $118,415.04 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide reagents and supplies needed to perform HIV, HBV, and HCV (molecular) testing. The contract was awarded through the GSA's Critical Analyzers, Laboratory (FSS-66-III) schedule and does not have a set-aside designation. Roche Diagnostics has provided similar laboratory equipment, reagents, and...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $5,478,780.08 contract is for the provision of Roche Cobas 6800 HCV and HIV reagents. This award is not associated with a set-aside program. Roche Diagnostics has extensive experience as a prime contractor and subcontractor providing medical equipment, supplies, and services to various...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $199,928.52, is for the delivery of interim molecular HIV and HCV testing services through a 5-year Blanket Purchase Agreement (BPA) and an Indefinite Delivery Contract (IDC). These provide the VA with...
- This federal contract award to Roche Diagnostics Corporation (Roche), a manufacturer and distributor of in vitro diagnostics, provides the Department of Veterans Affairs (VA) with COBAS AMPLIPREP/COBAS TAQMAN HCV V 2.0 and COBAS AMPLIPREP/COBAS TAQMAN HIV-1 V.2.0 test kits. The $542,265.60 firm fixed-price purchase order has a completion date of May 31, 2017. Roche has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) to supply laboratory instruments, reagents, test...
- This federal contract award is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation for the provision of HIV, HBV, and HCV testing reagents and supplies. The contract has a ceiling value of $137,020.35 and an ultimate completion date of April 14, 2025. The contract is not set aside and was awarded under the GSA Schedule 66-III for Critical Analyzers, Laboratory. Roche Diagnostics Corporation is a foreign-owned, for-profit...
- This federal contract award, valued at $163,341.11, was made by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and related products and services. The award is for the provision of HCV and HIV reagent kits, which are critical for patient care and testing at VA hospitals and clinics. The contract is a Blanket Purchase...